Younossi, Zobair M. https://orcid.org/0000-0001-9313-577X
Zelber-Sagi, Shira
Henry, Linda
Gerber, Lynn H.
Article History
Accepted: 26 May 2023
First Online: 4 July 2023
Competing interests
: Z.Y. has received research funding and/or serves as a consultant to Intercept, Cymabay, Boehringer Ingelheim, BMS, GSK, NovoNordisk, AstraZeneca, Siemens, Madridgal, Merck and Abbott. The remaining authors declare no competing interests.